Similar articles

• Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects.

  Grundmann O, Hill K, Al Barzanji E, Hazrat NG, Kaur G, Negeve RE, Shade S, Weber S, Veltri CA. Grundmann O, et al. J Ethnopharmacol. 2023 Dec 5;317:116779. doi: 10.1016/j.jep.2023.116779. Epub 2023 Jun 24. J Ethnopharmacol. 2023. PMID: 37364801
• Endogenous Opioid Activity as the Mechanism of Action for Mitragyna speciosa (Kratom): The Current State of the Evidence.

  Bowe A, Kerr PL. Bowe A, et al. Adv Neurobiol. 2024;35:287-313. doi: 10.1007/978-3-031-45493-6_15. Adv Neurobiol. 2024. PMID: 38874729 Review.
• Kratom: An Emerging Issue and Need for Regulations in the United States.

  Shah K, Tankersley W, Mekala H. Shah K, et al. Prim Care Companion CNS Disord. 2021 Feb 18;23(1):20r02770. doi: 10.4088/PCC.20r02770. Prim Care Companion CNS Disord. 2021. PMID: 34000147
• The Use of Benzodiazepines among Kratom (Mitragyna Speciosa Korth.) Users.

  Singh D, Narayanan S, Grundmann O, Boyer EW, Vicknasingam B. Singh D, et al. J Psychoactive Drugs. 2020 Jan-Mar;52(1):86-92. doi: 10.1080/02791072.2019.1632505. Epub 2019 Jun 20. J Psychoactive Drugs. 2020. PMID: 31218929
• Kratom (Mitragyna speciosa): worldwide issues.

  Ramanathan S, McCurdy CR. Ramanathan S, et al. Curr Opin Psychiatry. 2020 Jul;33(4):312-318. doi: 10.1097/YCO.0000000000000621. Curr Opin Psychiatry. 2020. PMID: 32452943 Review.